Table 8.

Sensitivity analysis results for a time horizon of 2 years: variation of HPV prevalence

Prevalence	Additional tests* versus Aptima, n =	Additional costs versus Aptima, €
Lower value (10.5%)
Hybrid Capture® 2	265,652	354,096,906.62 €**
Cobas® 4800	276,698	2,868,712.91 €
Higher value (25.4%)
Hybrid Capture® 2	243,924	540,093,540.88 €**
Cobas® 4800	230,360	2,387,698.92 €

Legend: Aptima: Aptima® HPV.

*Includes HPV tests and other diagnostic tests (cytology, colposcopy, and biopsy)

**Includes the cost of HPV genotyping after the first and subsequent Hybrid Capture® 2 tests